PureTech Health (GB:PRTC) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Seaport Therapeutics, backed by PureTech Health, has strengthened its executive team by appointing Antony Loebel, M.D., as Chief Medical Officer and Lana Gladstein, J.D., as General Counsel. Both bring significant expertise, with Loebel having successfully led CNS drug development at Sunovion Pharmaceuticals and Gladstein offering over two decades of legal experience in the biotech sector. The appointments come as Seaport advances its pipeline of novel neuropsychiatric medicines, aiming to address unmet patient needs.
For further insights into GB:PRTC stock, check out TipRanks’ Stock Analysis page.